chr11-77192192-A-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_000260.4(MYO7A):​c.4066A>T​(p.Ser1356Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00040 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000038 ( 0 hom. )

Consequence

MYO7A
NM_000260.4 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:1

Conservation

PhyloP100: 2.59
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.049691677).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYO7ANM_000260.4 linkuse as main transcriptc.4066A>T p.Ser1356Cys missense_variant 31/49 ENST00000409709.9 NP_000251.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYO7AENST00000409709.9 linkuse as main transcriptc.4066A>T p.Ser1356Cys missense_variant 31/491 NM_000260.4 ENSP00000386331 Q13402-1

Frequencies

GnomAD3 genomes
AF:
0.000401
AC:
61
AN:
152260
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000642
AC:
16
AN:
249208
Hom.:
0
AF XY:
0.0000518
AC XY:
7
AN XY:
135206
show subpopulations
Gnomad AFR exome
AF:
0.00103
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000376
AC:
55
AN:
1461674
Hom.:
0
Cov.:
32
AF XY:
0.0000358
AC XY:
26
AN XY:
727116
show subpopulations
Gnomad4 AFR exome
AF:
0.00149
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
AF:
0.000401
AC:
61
AN:
152260
Hom.:
0
Cov.:
33
AF XY:
0.000417
AC XY:
31
AN XY:
74390
show subpopulations
Gnomad4 AFR
AF:
0.00145
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000881
Hom.:
0
Bravo
AF:
0.000442
ESP6500AA
AF:
0.00233
AC:
10
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000107
AC:
13

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 01, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJan 12, 2023In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJun 04, 2015- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 30, 2024Variant summary: MYO7A c.4066A>T (p.Ser1356Cys) results in a non-conservative amino acid change located in the FERM domain (IPR000299) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 249208 control chromosomes, predominantly at a frequency of 0.001 within the African or African-American subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in MYO7A causing Usher Syndrome (6.4e-05 vs 0.0061), allowing no conclusion about variant significance. c.4066A>T has been reported in the literature in the heterozygous state in an individual of African ancestry affected with profound congenital sensorineural hearing loss (Florentine_2022). This report does not provide unequivocal conclusions about association of the variant with Usher Syndrome or other MYO7A-related disorders. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 34515852). ClinVar contains an entry for this variant (Variation ID: 235215). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 17, 2022The c.4066A>T (p.S1356C) alteration is located in exon 31 (coding exon 30) of the MYO7A gene. This alteration results from a A to T substitution at nucleotide position 4066, causing the serine (S) at amino acid position 1356 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Usher syndrome type 1B Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Apr 16, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
21
DANN
Benign
0.96
DEOGEN2
Uncertain
0.65
D;.;.;T
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.21
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.89
D;D;D;D
M_CAP
Benign
0.044
D
MetaRNN
Benign
0.050
T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.20
N;N;.;.
MutationTaster
Benign
0.99
N;N;N
PrimateAI
Benign
0.40
T
PROVEAN
Uncertain
-3.6
D;D;D;D
REVEL
Benign
0.15
Sift
Uncertain
0.015
D;D;D;D
Sift4G
Uncertain
0.036
D;D;D;D
Polyphen
0.0
B;.;.;.
Vest4
0.35
MVP
0.79
MPC
0.083
ClinPred
0.078
T
GERP RS
4.7
Varity_R
0.21
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201195495; hg19: chr11-76903237; COSMIC: COSV101289088; COSMIC: COSV101289088; API